8.70000 EUR
0.15
1.69%
Last update Dec 16, 6:46 PM CET
Main market
Day range
8.70000
8.85000
Previous close
8.85000
Open
8.85000
Access this stock data via API
Subscribe
Innovent Biologics Inc.
8.70
0.15
1.69%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 1.1B 750.2M 545.5M 4.3B
Cost of revenue 182.6M 137.4M 111.5M 505.3M
Gross profit 956.4M 612.8M 434.0M 3.8B
Operating expense
Research & development 324.1M 269.3M 343.7M 2.3B
Selling general and admin 614.7M 465.5M 410.2M 3.4B
Other operating expenses
Operating income 31.2M -109.9M -309.1M -1.9B
Non operating interest income
Income 51.2M 54.7M 22.7M 151.8M
Expense 8.2M 11.9M 12.2M 62.5M
Other income expense
Pretax income -9.5M -138.3M -259.8M -2.6B
Tax provision 1.9M -14.1M 1.1M 87.0M
Net income -11.4M -124.3M -260.9M -2.7B
Basic EPS -0.1 -0.7 -1.5 -1.9
Diluted EPS -0.1 -0.7 -1.5 -1.9
Basic average shares 196.7M 188.5M 178.4M 12.0B
Diluted average shares 196.7M 188.5M 178.4M 12.0B
EBITDA 30.6M -83.5M -210.1M -2.5B
Net income from continuing op. -9.5M -138.3M -259.8M -2.6B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 55 minutes

09:04
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).